JuSik Shin - InBody CoLtd Ex Officer
| 041830 Stock | KRW 22,850 350.00 1.56% |
Insider
JuSik Shin is Ex Officer of InBody CoLtd
| Phone | 82 2 501 3939 |
| Web | https://www.inbody.com/global |
InBody CoLtd Management Efficiency
The company has return on total asset (ROA) of 0.1152 % which means that it generated a profit of $0.1152 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 18.8439 %, meaning that it generated $18.8439 on every $100 dollars invested by stockholders. InBody CoLtd's management efficiency ratios could be used to measure how well InBody CoLtd manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| You WeonKyoo | ABL Bio | N/A | |
| Jong Won | ABL Bio | N/A | |
| Jeong Noh | SillaJen | 66 | |
| Gyeong Ha | SillaJen | 45 | |
| Jung Kim | ABL Bio | N/A | |
| YeongGuk Cho | Woori Technology Investment | N/A | |
| Changman Chae | Woori Technology Investment | N/A | |
| Byeong Kim | SillaJen | 51 | |
| Hyeok Gwon | SillaJen | 51 | |
| Junghoon Lee | Woori Technology Investment | 46 | |
| Gyeong Hwang | SillaJen | 42 | |
| Hyeon Shin | SillaJen | 47 | |
| Cheol Park | SillaJen | 52 | |
| Jong Park | SillaJen | 58 | |
| Gyeong Gook | SillaJen | 53 | |
| Seong Chi | SillaJen | 67 | |
| Jong Kim | ABL Bio | N/A | |
| Jae Jung | ABL Bio | N/A | |
| Sang Lee | ABL Bio | N/A | |
| Jin Soo | AptaBio Therapeutics | N/A | |
| KiJoo Lee | Woori Technology Investment | N/A | |
Management Performance
| Return On Equity | 18.84 | |||
| Return On Asset | 0.12 |
InBody CoLtd Management Team
Elected by the shareholders, the InBody CoLtd's board of directors comprises two types of representatives: InBody CoLtd inside directors who are chosen from within the company, and outside directors, selected externally and held independent of InBody. The board's role is to monitor InBody CoLtd's management team and ensure that shareholders' interests are well served. InBody CoLtd's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, InBody CoLtd's outside directors are responsible for providing unbiased perspectives on the board's policies.
| KiChul Cha, Chief Officer | ||
| JuSik Shin, Ex Officer | ||
| YoonSun Shin, Managing Director |
InBody Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is InBody CoLtd a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 18.84 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 331.29 B | |||
| Shares Outstanding | 13.48 M | |||
| Shares Owned By Insiders | 28.69 % | |||
| Shares Owned By Institutions | 19.22 % | |||
| Price To Earning | 30.89 X | |||
| Price To Sales | 2.02 X |
Pair Trading with InBody CoLtd
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InBody CoLtd position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InBody CoLtd will appreciate offsetting losses from the drop in the long position's value.Moving together with InBody Stock
Moving against InBody Stock
The ability to find closely correlated positions to InBody CoLtd could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InBody CoLtd when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InBody CoLtd - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InBody CoLtd to buy it.
The correlation of InBody CoLtd is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InBody CoLtd moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InBody CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InBody CoLtd can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in InBody Stock
InBody CoLtd financial ratios help investors to determine whether InBody Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in InBody with respect to the benefits of owning InBody CoLtd security.